A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

Clinical trial NCT06700070 · RECRUITING

Trial details

NCT number: NCT06700070
Sponsor: Pure Biologics S.A.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Soft Tissue Sarcoma Adult Triple Negative Breast Cancer

Start date: 2025-03-27
Primary completion: 2025-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.